Pretreatment with CDMP protected mice pulmonary fibrosis via significantly downregulating the secretion of TGF-β1 along with the decrease of IL-1β, IL-6, and TNF-α levels (Dong et al., 2020). This evidence concerns the gene TNF and pulmonary fibrosis.